Published in Lancet on August 15, 1998
Marine algal toxins: origins, health effects, and their increased occurrence. Environ Health Perspect (2000) 3.62
Heteroduplex mobility assay-guided sequence discovery: elucidation of the small subunit (18S) rDNA sequences of Pfiesteria piscicida and related dinoflagellates from complex algal culture and environmental sample DNA pools. Proc Natl Acad Sci U S A (2000) 2.88
Indicators of ocean health and human health: developing a research and monitoring framework. Environ Health Perspect (2002) 2.44
Development of real-time PCR assays for rapid detection of Pfiesteria piscicida and related dinoflagellates. Appl Environ Microbiol (2000) 2.35
Climate variability and change in the United States: potential impacts on water- and foodborne diseases caused by microbiologic agents. Environ Health Perspect (2001) 2.29
Reporter gene assay for fish-killing activity produced by Pfiesteria piscicida. Environ Health Perspect (1999) 2.20
Field ecology of toxic Pfiesteria complex species and a conservative analysis of their role in estuarine fish kills. Environ Health Perspect (2001) 1.76
Possible estuary-associated syndrome: symptoms, vision, and treatment. Environ Health Perspect (2001) 1.61
Estuary-associated syndrome in North Carolina: an occupational prevalence study. Environ Health Perspect (2001) 1.56
Identification of a P2X7 receptor in GH(4)C(1) rat pituitary cells: a potential target for a bioactive substance produced by Pfiesteria piscicida. Environ Health Perspect (2001) 1.41
Structure and absolute configuration of karlotoxin-2, an ichthyotoxin from the marine dinoflagellate Karlodinium veneficum. J Am Chem Soc (2010) 1.29
Species of the toxic Pfiesteria complex, and the importance of functional type in data interpretation. Environ Health Perspect (2001) 1.26
Characterization of the rRNA locus of Pfiesteria piscicida and development of standard and quantitative PCR-based detection assays targeted to the nontranscribed spacer. Appl Environ Microbiol (2002) 1.21
Demonstration of toxicity to fish and to mammalian cells by Pfiesteria species: comparison of assay methods and strains. Proc Natl Acad Sci U S A (2005) 1.12
Are Pfiesteria species toxicogenic? Evidence against production of ichthyotoxins by Pfiesteria shumwayae. Proc Natl Acad Sci U S A (2002) 1.03
Skin ulcers in estuarine fishes: a comparative pathological evaluation of wild and laboratory-exposed fish. Environ Health Perspect (2001) 0.98
Cohort studies of health effects among people exposed to estuarine waters: North Carolina, Virginia, and Maryland. Environ Health Perspect (2001) 0.96
Pfiesteria: review of the science and identification of research gaps. Report for the National Center for Environmental Health, Centers for Disease Control and Prevention. Environ Health Perspect (2001) 0.96
Characterization of ichthyocidal activity of Pfiesteria piscicida: dependence on the dinospore cell density. Appl Environ Microbiol (2005) 0.95
Residential and recreational acquisition of possible estuary-associated syndrome: a new approach to successful diagnosis and treatment. Environ Health Perspect (2001) 0.87
Discovery of the toxic dinoflagellate Pfiesteria in northern European waters. Proc Biol Sci (2002) 0.87
Occupational exposure to pfiesteria species in estuarine waters is not a risk factor for illness. Environ Health Perspect (2006) 0.86
Potential human health effects associated with laboratory exposures to Pfiesteria piscicida. Environ Health Perspect (2001) 0.86
A rat model of the cognitive impairment from Pfiesteria piscicida exposure. Environ Health Perspect (2001) 0.85
Human health effects and Pfiesteria exposure: a synthesis of available clinical data. Environ Health Perspect (2001) 0.82
Microfluorimetric analysis of a purinergic receptor (P2X7) in GH4C1 rat pituitary cells: effects of a bioactive substance produced by Pfiesteria piscicida. Environ Health Perspect (2001) 0.81
Environmental public health surveillance: possible estuary-associated syndrome. Environ Health Perspect (2001) 0.79
State monitoring activities related to Pfiesteria-like organisms. Environ Health Perspect (2001) 0.77
Effect of biotic and abiotic factors on in vitro proliferation, encystment, and excystment of Pfiesteria piscicida. Appl Environ Microbiol (2007) 0.77
Emerging areas of research reported during the CDC National Conference on Pfiesteria: from biology to public health. Environ Health Perspect (2001) 0.75
Pfiesteria in estuarine waters: the question of health risks. Environ Health Perspect (2007) 0.75
Lack of evidence for contact sensitization by Pfiesteria extract. Environ Health Perspect (2007) 0.75
Tularemia as a biological weapon: medical and public health management. JAMA (2001) 13.23
Cholera. Clin Microbiol Rev (1995) 12.33
Botulinum toxin as a biological weapon: medical and public health management. JAMA (2001) 9.18
Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med (2001) 8.47
Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (2000) 8.45
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.06
Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis (1999) 5.99
Cholera and other vibrioses in the United States. N Engl J Med (1985) 5.17
Bacteriophage therapy. Antimicrob Agents Chemother (2001) 5.16
A clinical trial of change in maternal smoking and its effect on birth weight. JAMA (1984) 5.12
Oxygen and the growth and metabolism of Clostridium acetobutylicum. J Gen Microbiol (1971) 4.91
Human immunodeficiency virus infection among patients attending clinics for sexually transmitted diseases. N Engl J Med (1988) 4.81
Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev (1995) 4.64
Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques. Infect Immun (1988) 4.44
Clostridium difficile colitis: an efficient clinical approach to diagnosis. Ann Intern Med (1995) 4.42
Complete nucleotide sequence of a milk-transmitted mouse mammary tumor virus: two frameshift suppression events are required for translation of gag and pol. J Virol (1987) 4.37
An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. Development (2000) 4.33
A new integrated genetic linkage map of the soybean. Theor Appl Genet (2004) 4.21
Recovery from hip fracture in eight areas of function. J Gerontol A Biol Sci Med Sci (2000) 4.19
Emerging foodborne pathogens: Escherichia coli O157:H7 as a model of entry of a new pathogen into the food supply of the developed world. Epidemiol Rev (1996) 4.09
Sequence, topography and protein coding potential of mouse int-2: a putative oncogene activated by mouse mammary tumour virus. EMBO J (1986) 4.08
Tumorigenesis by mouse mammary tumor virus: evidence for a common region for provirus integration in mammary tumors. Cell (1983) 3.89
Predictors of functional recovery one year following hospital discharge for hip fracture: a prospective study. J Gerontol (1990) 3.65
Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res (1994) 3.65
Tumorigenesis by mouse mammary tumor virus: proviral activation of a cellular gene in the common integration region int-2. Cell (1984) 3.61
Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proc Natl Acad Sci U S A (2004) 3.57
Harlequin syndrome: the sudden onset of unilateral flushing and sweating. J Neurol Neurosurg Psychiatry (1988) 3.47
Phenotypic evaluation of acapsular transposon mutants of Vibrio vulnificus. Infect Immun (1990) 3.47
Rapid radiometric susceptibility testing of Mycobacterium tuberculosis. Am Rev Respir Dis (1978) 3.43
The NF-kappa B binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity. J Virol (1989) 3.36
Automatic radiometric measurement of antibiotic effect on bacterial growth. Antimicrob Agents Chemother (1972) 3.27
Non-O group 1 Vibrio cholerae gastroenteritis in the United States: clinical, epidemiologic, and laboratory characteristics of sporadic cases. Ann Intern Med (1981) 3.25
Subcellular fate of the int-2 oncoprotein is determined by choice of initiation codon. Nature (1990) 3.19
Automated detection of Haemophilus influenzae. Appl Microbiol (1973) 3.16
Genome organization in dicots: genome duplication in Arabidopsis and synteny between soybean and Arabidopsis. Proc Natl Acad Sci U S A (2000) 3.07
Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans. J Clin Invest (1987) 3.03
The role of 'no-touch' automated room disinfection systems in infection prevention and control. J Hosp Infect (2012) 2.97
RFLP mapping in soybean: association between marker loci and variation in quantitative traits. Genetics (1990) 2.97
Detection of surgical pathogens by in vitro DNA amplification. Part I. Rapid identification of Candida albicans by in vitro amplification of a fungus-specific gene. Surgery (1990) 2.93
A new route of transmission for Escherichia coli: infection from dry fermented salami. Am J Public Health (1996) 2.78
Vibrio cholerae O139 synonym bengal is closely related to Vibrio cholerae El Tor but has important differences. Infect Immun (1994) 2.73
Excess mortality attributable to hip fracture in white women aged 70 years and older. Am J Public Health (1997) 2.68
Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet (1991) 2.60
Evaluation of DNA colony hybridization and other techniques for detection of virulence in Yersinia species. J Clin Microbiol (1989) 2.58
Studies on gonococcus infection. V. Observations on in vitro interactions of gonococci and human neutrophils. Infect Immun (1974) 2.57
CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1. Oncogene (1994) 2.55
Potential oncogene product related to growth factors. Nature (1987) 2.53
Production of Solvents by Clostridium acetobutylicum Cultures Maintained at Neutral pH. Appl Environ Microbiol (1984) 2.51
Placing paleopolyploidy in relation to taxon divergence: a phylogenetic analysis in legumes using 39 gene families. Syst Biol (2005) 2.48
A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group. Crit Care Med (1995) 2.48
Back pain: a randomized clinical trial of rotational manipulation of the trunk. Br J Ind Med (1974) 2.47
Survival experience of aged hip fracture patients. Am J Public Health (1989) 2.46
Identification and cloning of a novel plasmid-encoded enterotoxin of enteroinvasive Escherichia coli and Shigella strains. Infect Immun (1995) 2.45
Patient-proxy response comparability on measures of patient health and functional status. J Clin Epidemiol (1988) 2.42
Cloning of the cytotoxin-hemolysin gene of Vibrio vulnificus. Infect Immun (1985) 2.42
Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection. Hepatology (2001) 2.38
On the permeability to weak acids and bases of the cytoplasmic membrane of Clostridium pasteurianum. Biochem Biophys Res Commun (1981) 2.32
Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease. Int J Cancer (1990) 2.28
The capsule and O antigen in Vibrio cholerae O139 Bengal are associated with a genetic region not present in Vibrio cholerae O1. Infect Immun (1995) 2.25
Concerted activation of two potential proto-oncogenes in carcinomas induced by mouse mammary tumour virus. Nature (1986) 2.24
D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene (1991) 2.21
Fibroblast growth factor receptor 2-IIIb acts upstream of Shh and Fgf4 and is required for limb bud maintenance but not for the induction of Fgf8, Fgf10, Msx1, or Bmp4. Dev Biol (2001) 2.21
Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract. Mol Microbiol (2002) 2.18
Illness caused by Vibrio damsela and Vibrio hollisae. Lancet (1982) 2.17
Wall-defective microbial variants: terminology and experimental design. J Infect Dis (1971) 2.16
Low bone mineral density and risk of fracture in white female nursing home residents. JAMA (2000) 2.15
Isolation of vancomycin-resistant enterococci from animal feed in USA. Lancet (1999) 2.12
PCR method for detection of adenovirus in urine of healthy and human immunodeficiency virus-infected individuals. J Clin Microbiol (1998) 2.12
Proxy reporting in five areas of functional status. Comparison with self-reports and observations of performance. Am J Epidemiol (1997) 2.11
Distribution of Vibrio vulnificus in the Chesapeake Bay. Appl Environ Microbiol (1996) 2.10
The value of fungal surveillance cultures as predictors of systemic fungal infections. J Infect Dis (1980) 2.10
Expression of the FGF-related proto-oncogene int-2 during gastrulation and neurulation in the mouse. EMBO J (1988) 2.08
The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years. J Neurol Neurosurg Psychiatry (1999) 2.07
Non-O:1 Vibrio cholerae bacteremia: case report and review. Rev Infect Dis (1988) 2.07
Psychoactive substance use disorders among seriously injured trauma center patients. JAMA (1997) 2.05
Septic shock: an analysis of outcomes for patients with onset on hospital wards versus intensive care units. Crit Care Med (1998) 2.04
Half-time and high-speed running in the second half of soccer. Int J Sports Med (2012) 2.03
Cryptosporidiosis in an immunosuppressed renal-transplant recipient with IgA deficiency. Am J Clin Pathol (1979) 2.03
Limits of applicability of the firefly luminescence ATP assay for the detection of bacteria in clinical specimens. Am J Clin Pathol (1975) 2.01
Cloning and sequence of a region encoding a surface polysaccharide of Vibrio cholerae O139 and characterization of the insertion site in the chromosome of Vibrio cholerae O1. Mol Microbiol (1996) 2.01
Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein. Oncogene (1994) 1.99
Multiple eruptive dermatofibromas in an HIV-positive man. Dermatology (1995) 1.97
Comparison of DNA probes and the Sereny test for identification of invasive Shigella and Escherichia coli strains. J Clin Microbiol (1986) 1.96
Utilization of L-threonine by a species of Arthrobacter. A novel catabolic role for "aminoacetone synthase". Biochem J (1969) 1.95
Traditional risk factors and ischemic stroke in young adults: the Baltimore-Washington Cooperative Young Stroke Study. Arch Neurol (1996) 1.94
Rapid identification of Vibrio vulnificus on nonselective media with an alkaline phosphatase-labeled oligonucleotide probe. Appl Environ Microbiol (1993) 1.94
The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection. J Hosp Infect (1995) 1.94
Identification of environmental Vibrio vulnificus isolates with a DNA probe for the cytotoxin-hemolysin gene. Appl Environ Microbiol (1987) 1.94
Morphological and biochemical characterization of viral particles produced by the tsO45 mutant of vesicular stomatitis virus at restrictive temperature. J Virol (1979) 1.93
Nosocomial pneumonia. A continuing major problem. Am Rev Respir Dis (1973) 1.91
Characterization and chromosome assignment of the human homolog of int-2, a potential proto-oncogene. Mol Cell Biol (1986) 1.90
The extracellular cytolysin of Vibrio vulnificus: inactivation and relationship to virulence in mice. Infect Immun (1991) 1.87
Protein-coding potential of mouse mammary tumor virus genome RNA as examined by in vitro translation. J Virol (1981) 1.87
Non-O1 Vibrio cholerae NRT36S produces a polysaccharide capsule that determines colony morphology, serum resistance, and virulence in mice. Infect Immun (1992) 1.86
Superoxide dismutase in some obligately anaerobic bacteria. FEBS Lett (1975) 1.85
The prevalence of dementia in a statewide sample of new nursing home admissions aged 65 and older: diagnosis by expert panel. Epidemiology of Dementia in Nursing Homes Research Group. Gerontologist (2000) 1.84
The int-2 gene product acts as an epithelial growth factor in transgenic mice. EMBO J (1990) 1.82
Purification and determination of the structure of capsular polysaccharide of Vibrio vulnificus M06-24. J Bacteriol (1992) 1.81